From other sites
at 4-traders.com (Aug 21, 2015)
Cellectar Biosciences : Introduces Phospholipid Ether-Drug Conjugate (PDC) Platform for Targeted Delivery of Chemotherapeuticsat 4-traders.com (Aug 21, 2015)
at 4-traders.com (Jul 31, 2015)
CLRB vs. ETF Alternatives
Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents and therapeutic agents.
Other News & PR